A breakthrough in nanomedicine has been made by researchers at the University of California, San Diego. They have developed a new type of nanoparticle that can specifically target pancreatic cells in mice. This is a major step forward in the field of targeted drug delivery, as it could be used to deliver drugs and other therapeutic molecules directly to organs and cells that need them. The lipid nanoparticles are also biocompatible, meaning they are safe for human use. This opens up the potential for using these nanoparticles to treat a wide range of diseases in humans.

Read Full Article Here

source: Phys.org